𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clearance of hepatitis b virus dna and pre-s surface antigens in patients with markers of acute viral replication

✍ Scribed by Dr. C. Delfini; S. Colloca; T. Stroffolini; G. Taliani; F. Mazzotta; A. D'Agata; C. Buonamici; G. Carloni


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
678 KB
Volume
28
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


To clarify the relationship between the pre-S antigens and other serological markers of hepatitis B virus (HBV) replication, we followed up 27 patients: 21 presented with symptoms of acute hepatitis (two progressed to chronicity) and six suffered from chronic hepatitis. Pre-S1, pre-S2, HBV DNA, IgM antihepatitis core antigen (HBc), hepatitis B e antigen (HBeAg), and anti-HBe were detected in about 200 sera serially collected at different times for at least 6-12 months from the onset of clinical observation. In the early symptomatic phase of acute hepatitis, the pre-S1 and pre-S2 antigens were present in 95% of the cases and correlated well with high levels of alanine-transferase (ALT) and IgM anti-HBc, while HBV DNA was present in the sera of only six (28.6%) patients (P less than 0.0001). This was the first marker to disappear (1 month after the initial stage). All of the HBV DNA-positive patients were also HBeAg positive, whereas no HBeAg-negative subjects were found with serum HBV DNA. In the six chronic patients, pre-S antigens were always present independently of the HBeAg/anti-HBe status; HBV DNA was detected in three of them, even if transiently, and in two of these it reappeared together with pre-S2 epitope. The follow-up data suggest that, in acute hepatitis, the clearance of pre-S antigens can be considered as a prognostic index of clinical resolution and that, in chronic hepatitis, the persistence of pre-S antigens seems to indicate progression of the disease. In particular, pre-S2, in patients in whom it is intermittent, can be considered as an index of reactivation.


πŸ“œ SIMILAR VOLUMES


Clearance of pre-S2 antigen: A marker of
✍ Javier Brahm; Graeme J. M. Alexander; Elizabeth A. Fagan; Heather M. Smith; Hele πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 353 KB

The relation between viral replication, the presence of HBsAg and pre-S2 in serum and eventual clinical outcome has been investigated in fourteen patients undergoing treatment with lymphoblastoid interferon for chronic hepatitis B virus (HBV) infection. In four patients permanent loss of pre-S2 was

Detection of hepatitis B viral DNA by po
✍ Ling-Na Shih; Jin-Chuan Sheu; Jin-Town Wang; Guan-Tarn Huang; Juei-Suei Chen; Ju πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 690 KB

## Abstract Hepatitis B virus (HBV) DNA was assayed using the polymerase chain reaction in serum samples of 116 hepatitis B surface antigen (HBsAg) carriers, including 30 positive for hepatitis B e antigen (HBeAg) and 86 negative for HBeAg. In the HBeAg‐positive group, all were positive for HBV DNA

Serum titers of pre-S(2) antigen in pati
✍ Kiyohiko Kurai; Shiro Iino; Kazuhiko Koike; Keiji Mitamura; Yasuo Endo; Hiroshi πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 503 KB

The peptide which is encoded by the pre-S(2) region of hepatitis B virus DNA, the pre-S(2) antigen, was determined quantitatively by an enzyme immunoassay system employing monoclonal antibodies. The prevalence and titer of pre-S(2)Ag were 91.9% (91/99) and 10,356 2 19,053 units (mean f S.D., arbitra

Hepatitis B virus DNA in liver, serum, a
✍ Yoshiki Murakami; Masahito Minami; Yukiko Daimon; Takeshi Okanoue πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 190 KB

## Abstract The integration of hepatitis B virus (HBV) DNA in the liver of chronic HBV carriers has been documented extensively. However, the status of the viral genome during acute infection has not been assessed conclusively. While HBV DNA sequences are detected often in serum, liver, and periphe

Clearance of hepatitis B surface antigen
✍ Josephine Simonetti; Lisa Bulkow; Brian J. McMahon; Chriss Homan; Mary Snowball; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 2 views

Some individuals who are chronically infected with hepatitis B virus (HBV) eventually lose hepatitis B surface antigen (HBsAg). Hepatocellular carcinoma (HCC) has been demonstrated to occur in a few patients after loss of HBsAg. Neither factors associated with loss of HBsAg nor the incidence of HCC